Rapamycin shows promise in slowing Alzheimer’s disease progression linked to seizures

FHS
May 2, 2024
4:37 pm

Protein imbalances that increase brain cell excitability may explain why individuals with Alzheimer’s disease (AD) who also experience seizures demonstrate more rapid cognitive decline than those who do not experience seizures.

Survey Shows Public’s Growing Acceptance of Magic Mushrooms | Psychedelic Invest

In a landmark study on the “moral status” of psilocybin, nearly 9 out of 10 Americans have voiced their approval for the controlled, licensed use

March 11, 2024

Study highlights COVID-19 challenges for perinatal women in Latino communities

Public policies blocked many families of Mexican descent living in the U.S. from accessing vital services such as food and mental health care during the

April 5, 2024

Early Enthusiasm for Cancer Drug Reformulated for Ophthalmic Use

SEATTLE — An ocular implant containing a reformulated cancer drug preserved vision and stabilized retinal thickening for up to a year while dramatically reducing treatment

August 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.